Imperial College London

Professor Claire Shovlin

Faculty of MedicineNational Heart & Lung Institute

Professor of Practice (Clinical and Molecular Medicine)
 
 
 
//

Contact

 

c.shovlin Website

 
 
//

Location

 

534Block L Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Dupuis-Girod:2017:10.1159/000479632,
author = {Dupuis-Girod, S and Cottin, V and Shovlin, CL},
doi = {10.1159/000479632},
journal = {Respiration},
pages = {315--330},
title = {The Lung in Hereditary Hemorrhagic Telangiectasia},
url = {http://dx.doi.org/10.1159/000479632},
volume = {94},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inherited genetic vascular disorder with an estimated prevalence of 1 in 6,000, characterized by recurrent epistaxis, cutaneous telangiectasia, and arteriovenous malformations (AVMs) that affect many organs including the lungs, gastrointestinal tract, liver, and brain. Its diagnosis is based on the Curaçao criteria, and is considered definite if at least 3 of the 4 following criteria are fulfilled: (1) spontaneous and recurrent epistaxis, (2) telangiectasia, (3) a family history, and (4) pulmonary, liver, cerebral, spinal, or gastrointestinal AVMs. The focus of this review is on delineating how HHT affects the lung.
AU - Dupuis-Girod,S
AU - Cottin,V
AU - Shovlin,CL
DO - 10.1159/000479632
EP - 330
PY - 2017///
SN - 1423-0356
SP - 315
TI - The Lung in Hereditary Hemorrhagic Telangiectasia
T2 - Respiration
UR - http://dx.doi.org/10.1159/000479632
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411509800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - http://hdl.handle.net/10044/1/63381
VL - 94
ER -